Viewing Study NCT01156532


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2026-01-05 @ 2:44 PM
Study NCT ID: NCT01156532
Status: TERMINATED
Last Update Posted: 2014-08-25
First Post: 2010-07-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy
Sponsor: AbbVie (prior sponsor, Abbott)
Organization: